Back to search
FDAFDA · Food and drugs·Recall number D-0147-2025

Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada.

Published December 25, 2024 · Recall initiated: November 14, 2024

Summary

FDA records drug Class II recall D-0147-2025, published December 25, 2024 and initiated November 14, 2024. Recalling firm: Keystone Industries; Status: Terminated; Lot: Lot No.: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-35119. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Keystone Industries
Distributor
Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.
Lot
Lot No.: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-35119
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada. recalled?

Yes. FDA published recall D-0147-2025 on December 25, 2024. Reported hazard: CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail